ctrl K

Watchlist Price Alert

Unicycive Therapeutics In... (UNCY)

NASDAQ: UNCY · Real-Time Price · USD

5.99

-0.22 (-3.54%)

At close: Jun 26, 2025, 3:59 PM

6.25

4.34%

Pre-market: Jun 27, 2025, 07:12 AM EDT

Unicycive Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	675K	951K	n/a	n/a	n/a	n/a
Cost of Revenue	428K	n/a	7K	1K	n/a	n/a	n/a
Gross Profit	n/a	675K	944K	-1K	n/a	n/a	n/a
Operating Income	-32.12M	-20.77M	-18.05M	-8.98M	-2.02M	-1.96M	-952K
Interest Income	1.26M	615K	6K	628K	244K	139K	168K
Pretax Income	-37.82M	-30.54M	-18.06M	-10.02M	-2.26M	-2.17M	-1.12M
Net Income	-36.73M	-30.54M	-18.06M	-10.63M	-2.51M	-2.3M	-1.12M
Selling & General & Admin	12.1M	8.55M	6.57M	2.9M	1M	1.17M	608K
Research & Development	20.01M	12.9M	12.44M	6.08M	1.01M	795K	344K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	32.12M	21.45M	19M	8.98M	2.02M	1.96M	952K
Interest Expense	71K	82K	6K	628K	244K	139K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	-32.12M	21.45M	19M	8.98M	2.02M	1.96M	952K
Income Tax Expense	-1.09M	n/a	6K	615K	244K	139K	-952K
Shares Outstanding (Basic)	66.99M	2.45M	1.51M	1.5M	1.52M	842.5K	794.32K
Shares Outstanding (Diluted)	66.99M	2.45M	1.51M	1.5M	1.52M	847.15K	794.32K
EPS (Basic)	-0.06	-1.28	-1.2	-0.71	-0.16	-0.27	-0.14
EPS (Diluted)	-0.06	-1.28	-1.2	-0.71	-0.16	-0.27	-0.14
EBITDA	-36.23M	-30.18M	-18.05M	-8.98M	n/a	-63K	n/a
EBIT	-37.9M	-30.46M	-18.05M	-8.98M	-2.02M	-2.03M	-952K
Depreciation & Amortization	428K	284K	7K	1K	2.02M	1.96M	952K